We are live on !
Find out more
Cheviot Value Management Portfolio holdings
AUM
$1.03B
Turnover
20.7%
1-Year Est. Return
18.09%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+18.09%
3 Year Est. Return
+86.95%
5 Year Est. Return
+110.6%
10 Year Est. Return
+309.9%
AUM
$161M
AUM Growth
-$6.26M
(-3.7%)
Cap. Flow
-$7.99M
Cap. Flow % of AUM
Cap. Flow %
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
64.04%
Holding
43
New
4
Increased
2
Reduced
32
Closed
4
Avg Time Held
2.3
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Dividend ETF
SDY
|
+$276K |
| 2 |
Qualcomm
QCOM
|
+$268K |
| 3 |
Northern Trust Quality Dividend ETF
QDF
|
+$261K |
| 4 |
GG
Goldcorp Inc
GG
|
+$162K |
| 5 |
IMBI
iMedia Brands, Inc. Class A Common Stock
IMBI
|
+$31.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.15M |
| 2 |
Newmont
NEM
|
+$1.51M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$834K |
| 4 |
Microsoft
MSFT
|
+$708K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$430K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.91% |
| 2 | Financials | 24.44% |
| 3 | Miscellaneous | 13.27% |
| 4 | Materials | 11.23% |
| 5 | Technology | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.24T
| $27.1M | 16.8% |
187,325
-2,942
| -2% | -$430K |
2013 Q2
13 quarters
|
|
2
Johnson & Johnson
JNJ
$677B
| $12.4M | 7.67% |
104,568
-1,982
| -2% | -$240K |
2013 Q2
13 quarters
|
|
3
Sprott Physical Gold and Silver Trust
CEF
$6.71B
| $11.9M | 7.36% |
857,511
-12,362
| -1% | -$175K |
2013 Q2
13 quarters
|
|
|
4
Microsoft
MSFT
$3.95T
| $10M | 6.24% |
174,449
-12,534
| -7% | -$708K |
2013 Q2
13 quarters
|
|
|
5
Newmont
NEM
$124B
| $8.55M | 5.31% |
217,564
-36,472
| -14% | -$1.51M |
2013 Q2
13 quarters
|
|
|
6
VanEck Gold Miners ETF
GDX
$26.6B
| $8.1M | 5.03% |
306,549
-29,061
| -9% | -$834K |
2013 Q2
13 quarters
|
|
7
Pfizer
PFE
$166B
| $7.16M | 4.44% |
222,659
-2,978
| -1% | -$100K |
2013 Q2
13 quarters
|
|
8
Walmart Inc
WMT
$998B
| $6.74M | 4.18% |
280,353
-11,034
| -4% | -$268K |
2013 Q2
13 quarters
|
|
9
Medtronic
MDT
$130B
| $6.28M | 3.9% |
72,703
-1,375
| -2% | -$120K |
2013 Q2
13 quarters
|
|
10
American International
AIG
$42.5B
| $5.01M | 3.11% |
84,392
-4,624
| -5% | -$264K |
2013 Q2
13 quarters
|
|
11
Agnico Eagle Mines
AEM
$96.7B
| $4.82M | 2.99% |
88,993
-1,270
| -1% | -$70K |
2013 Q2
13 quarters
|
|
12
AbbVie
ABBV
$519B
| $4.49M | 2.79% |
71,147
-1,921
| -3% | -$124K |
2013 Q2
13 quarters
|
|
13
Pan American Silver
PAAS
$16.3B
| $4.39M | 2.73% |
249,158
-8,800
| -3% | -$165K |
2013 Q2
13 quarters
|
|
14
Markel Group
MKL
$24.2B
| $3.88M | 2.41% |
4,176
-43
| -1% | -$40.1K |
2013 Q2
13 quarters
|
|
15
Becton Dickinson
BDX
$58.3B
| $3.74M | 2.32% |
21,307
-10
| -0% | -$1.71K |
2013 Q2
13 quarters
|
|
16
McDonald's
MCD
$200B
| $3.66M | 2.27% |
31,737
-1,259
| -4% | -$149K |
2013 Q4
11 quarters
|
|
17
Apple
AAPL
$5.06T
| $3.55M | 2.2% |
125,556
-6,056
| -5% | -$160K |
2014 Q1
10 quarters
|
|
18
CVS Health
CVS
$112B
| $3.54M | 2.2% |
39,812
-1,043
| -3% | -$98.5K |
2013 Q2
13 quarters
|
|
19
Chevron
CVX
$411B
| $3.34M | 2.07% |
32,428
-485
| -1% | -$49.5K |
2013 Q2
13 quarters
|
|
|
20
Merck
MRK
$362B
| $3.16M | 1.96% |
53,094
-36,683
| -41% | -$2.15M |
2013 Q2
13 quarters
|
|
|
FFH
21
DELISTED
FAIRFAX FINL HLDGS LTD SUB VTG
FFH
| $2.98M | 1.85% |
5,091
-213
| -4% | -$125K |
2013 Q2
13 quarters
|
|
22
Abbott
ABT
$190B
| $2.63M | 1.64% |
62,285
-1,200
| -2% | -$51.4K |
2013 Q2
13 quarters
|
|
23
PepsiCo
PEP
$195B
| $2.44M | 1.51% |
22,406
-827
| -4% | -$89.1K |
2015 Q1
6 quarters
|
|
24
ExxonMobil
XOM
$669B
| $1.84M | 1.14% |
21,127
-999
| -5% | -$88.6K |
2015 Q3
4 quarters
|
|
25
AT&T
T
$147B
| $1.6M | 0.99% |
52,125
-1,960
| -4% | -$61.9K |
2015 Q3
4 quarters
|
|
Similar funds
RTM
Cheviot Value Management's Q3 2016 Portfolio in Review
As of Q3 2016, Cheviot Value Management held 43 positions worth $161M, down 3.7% from $167M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Cheviot Value Management withdrew a net $7.99M in Q3 2016, closing 4 positions and reducing 32 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $212K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Financials and Miscellaneous.
Against the trend, Cheviot Value Management opened a new position in State Street SPDR S&P Dividend ETF worth $273K.
- Cheviot Value Management's largest Q3 2016 buy was State Street SPDR S&P Dividend ETF: 3,239 shares worth $273K.
- Cheviot Value Management added most to Goldcorp Inc in Q3 2016, an estimated $162K increase.
- Cheviot Value Management's biggest Q3 2016 reduction was Merck, cutting an estimated $2.15M.
- Cheviot Value Management fully exited Walgreens Boots Alliance in Q3 2016, selling an estimated $212K.
- Cheviot Value Management's ten largest holdings make up 64% of its $161M portfolio in Q3 2016.
- Cheviot Value Management opened 4 new positions and closed 4 in Q3 2016.
- Cheviot Value Management's portfolio value fell 3.7% quarter-over-quarter to $161M.
Based on Cheviot Value Management's 13F filing for Q3 2016, filed 14 Nov 2016.